Sign up to save your podcasts
Or
Share Improving Outcomes in HER2+ Early Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Improving Outcomes in HER2+ Early Breast Cancer
CME credits: 0.25
Valid until: 14-09-2020
Claim your CME credit at https://reachmd.com/programs/cme/improving-outcomes-in-her2-early-breast-cancer/10925/
With clinical trials showing improvements over the current standard of care for HER2+ early breast cancer, incorporating new data and medications into this treatment paradigm is becoming a top priority. Listen in as Dr. Charles Geyer reviews the emerging approaches to adjuvant therapy in patients with HER2+ early breast cancer.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 14-09-2020
Claim your CME credit at https://reachmd.com/programs/cme/improving-outcomes-in-her2-early-breast-cancer/10925/
With clinical trials showing improvements over the current standard of care for HER2+ early breast cancer, incorporating new data and medications into this treatment paradigm is becoming a top priority. Listen in as Dr. Charles Geyer reviews the emerging approaches to adjuvant therapy in patients with HER2+ early breast cancer.